These three S&P/ASX All Ords (ASX: XAO) shares are having a mixed day on the market after the release of their latest results today.
Helia Group is the standout of these ASX All Ords shares after the company announced a big lift in earnings per share (EPS) and a sizeable combined interim and special dividend of 41 cents per share.
Let's take a look.
Image source: Getty Images
Helia Group Ltd (ASX: HLI)
Helia shareholders are throwing a party today after the company declared a combined 41-cent interim and special dividend and a 53% increase in undiluted earnings per share (EPS).
The ASX All Ords share is soaring today, up 16.25% to $3.255 apiece at the time of writing.
The mortgage insurance provider released its 2022 annual report today. It revealed a statutory net profit after tax (NPAT) of $186.8 million, down 3.1% on the prior corresponding period (pcp), and an underlying NPAT of $288.4 million, up 21.3% pcp. Statutory NPAT was materially lower as a result of pre-tax unrealised mark-to-market investment losses of $140.3 million due to rising bond rates.
The separation from Genworth Financial Inc (NYSE: GNW) was completed on time and under budget in H2 FY22. The company noted that it retained all its customers in the changeover process.
Both the interim and special dividends will be fully franked and payable on 24 March.
Impedimed Limited (ASX: IPD)
This ASX All Ords share fell to an intraday low of 5.6 cents, down 3.45%, before rebounding to be flat for the day at 5.8 cents at the time of writing.
In its half-year results, the medical devices company announced a 10% increase in revenue to $5,655,000 and a net loss attributable to members of $10,815,000 — up 21% pcp.
Impedimed said the oncology division would be its primary focus for 2H FY23. The company noted a need to look at private payer reimbursement, expanding the sales platform in advance of reimbursement, and completing the SOZO II hardware development and submitting it for US Food and Drug Administration (FDA) clearance.
Weebit Nano Ltd (ASX: WBT)
This ASX All Ords share is up 5.24% to $6.935 at the time of writing.
The semiconductor technology company also released its half-year results today. It reported no revenue and a $22,276,150 loss due to research and development costs. This is up 3.5% pcp.
The company said it had "achieved several key technical and commercial milestones" during the half.
Weebit expects to achieve its first revenue later in 2023. The company says it is "well positioned to productise its ReRAM technology".
